GBIO Stock Analysis: Buy, Sell, or Hold?
GBIO - Generation Bio Co. Common Stock
$5.34
-0.40 (-6.97%)
âŧ
5d:
-4.47%
30d:
-2.38%
90d:
+2.89%
WAIT
LOW Confidence
Analysis Updated: Feb 6, 2026 12:00 AM ET
Earnings: Mar 12, 2026
0d
Get Alerted When GBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: GBIO is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: GBIO is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: GBIO is currently trading at $5.34, which is considered fair based on recent price action.
Technical Outlook: Technically, GBIO is in a downtrend. The price is currently testing key support at $5.44. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.0% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GBIO is in a downtrend. The price is currently testing key support at $5.44. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.0% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
43/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
58.9%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BEARISH: Downward momentum (-7.0%)
- NEUTRAL: Near Wall St target ($5.25)
- WARNING: Composite score 43/100 in the bottom quintile â this cohort historically lags the market
Support & Resistance Levels
Support Level
$5.44
Resistance Level
$5.77
Current Trend
Downtrend
Technical data as of
Feb 6, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.69
Wall Street Target
$5.25
(-1.7%)
Revenue Growth (YoY)
-78.9%
Share & Embed Analysis
Last updated: September 02, 2026 3:32 AM ET
Data refreshes hourly during market hours. Next update: 4:32 AM
Data refreshes hourly during market hours. Next update: 4:32 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GBIO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 37 SELL |
|
REGN
Regeneron PharmaceuticalâĻ |
STRONG BUY
25 analysts |
$840 | 44 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$287 | 61 BUY |
|
MLTX
MoonLake ImmunotherapeutâĻ |
STRONG BUY
16 analysts |
$29 | 56 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$133 | 46 HOLD |
